Sanofi will pay Regeneron some $462 million in a revision of their deal in immuno-oncology, a growing sector in healthcare research which aims to help the body's own immune system fight cancer.
from Reuters: Health News https://reut.rs/2sd1wDk
via
IFTTT
0 comments:
Post a Comment